secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2023-08-25T23:59:59+00:00
Accession:  0001493152-23-030140
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions Q4 FY2023 revenue up 355% to $1.99M; net loss widens to $10.6M
--------------------------------------------------------------------------------

- Combined revenue & govt support income $1.99M (+355% YoY); product sales $1.26M.
- Net loss attributable to INBS $10.6M (vs $8.3M prior year); includes $4.2M goodwill impairment.
- Cash and equivalents $1.5M at June 30, 2023.
- Received FDA guidance for 510(k) pathway for its Intelligent Fingerprinting Drug Screening Cartridge.
- Expanded into Australia; secured 8 new customers; awarded 13th patent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315223030140/0001493152-23-030140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315223030140/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-030140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer